Leishmanicidal Activity of Films Containing Paromomycin and Gentamicin Sulfate both In Vitro and In Vivo

Background: Based on the efficacy of paromomycin ointment and recent ongoing clinical trials of combination of paromomycin and gentamicin, a new physical form of films of the paromomy­cin and gentamicin was prepared and anti-Leishmania activities of the prepared films were as­sessed in vitro and in vivo.Methods: Paromomycin 15% and gentamicin 0.5% was incorporated in a film using ethyl cellu­lose and HPMC (Hydroxyl Propyl Methyl Cellulose). In order to assess the drug release and anti-Leishmania activities of the preparation, a clone L. major parasite was established using a set of modified NNN medium without overlay liquid layer. Therapeutic effects of the films were evalu­ated using Balb/c mice model. The mice were inoculated with 2×106 L. major promastigotes (MRHO/IR/75/ER) and then when the lesions developed the mice were randomly divided in 3 groups, 10 mice per group, and treated with either perpetrated films or placebo for 28 days or left untreated.Results: Growth inhibition of cloned promastigotes showed that the films have enough releasing capacity and in vivo system, the films containing paromomycin and gentamicin was able to re­duce the lesion size and induced complete cure in 80% of the mice but relapse was seen in 60% of the cured mice and overall 50% cure rate was seen during 20 weeks period of the study.Conclusion: It seems that the prepared films might be further used in human clinical trials

The relationship between motivating tasks and academic resiliency: The mediating role of mastery goals and perceived competence

Background and Objectives:In academic situations, having the opportunity to succeed and rebuild learning increases students' self-confidence in achieving success. Teaching such learners the path to progress and showing the results of hard work makes them strive to master the learning situation. The result is a sense of control and autonomy along with a sense of value. Such instance causes the learner to insist, commit, and work harder without fear of failure to achieve success. Therefore, the importance of the present study is to theoretically determine and discover the model or how to place individual and environmental factors affecting academic resilience. From a practical point of view, this study aims to clarify the importance of individual and environmental factors affecting resilience in education. The aim of this study was to explore the relationship between motivating tasks and academic resiliency and Also determination mediating role of mastery goals and perceived competence. Methods: The present study utilizes a correlational research method using causal relationship modeling methods. The research method applied to this study was structural equation modeling. The target population of the study comprised Tehran universities students who were studying at education and psychology faculties in the academic year of 2014-2015. The sample consisted of 414 students who were selected by random cluster sampling method. In other words, the sampling unit was the classes rather than the individuals. The instruments used in this study were: Classroom Goals Structures, Achievement Goal Orientation, Perceived Competence Scale and Academic Resiliency Questionnaire.   Findings: The results revealed that motivating tasks has direct effect to predict academic resiliency. Furthermore, mastery goals and perceived competence mediated the relationship of motivating tasks with academic resiliency. Discussion and implications of the results are presented in the study. Conclusion: Based on this, it can be concluded that the setting of attractive and motivating tasks leads to the adoption of goals of mastery, self -esteem and control over the learning position of learners. Based on research results, the assignment variable as an extrinsic variable directly affects the resilience variable (dependent variable) and also through intermediate variables (proficiency goals and competency perception). In addition, the significance of the error estimation of each of the constructs shows that other external factors can also affect the relationship of the variables of this study with academic resilience. Based on this, it is suggested that other factors such as internal or external motivation and functional goals by learners be investigated as variables affecting the structural model. In order to apply the results of this research, it is recommended that academic centers be designed in such a way that learners face attractive and challenging tasks and provide them with the opportunity to succeed and experience a sense of competence.   ===================================================================================== COPYRIGHTS  ©2020 The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited. No permission is required from the authors or the publishers.  ====================================================================================

Effects of Cimetidine and Glucantime on cutaneous Leishmaniasis in Balb/c mice

سالک یکی از بیماری های بومی و شایع در برخی از نقاط کشور ماست. این عارضه پوستی یک بیماری انگلی است که توسط تک یاخته ای به نام لیشمانی (Leishmania) ایجاد و از طریق گزش پشه خاکی منتقل می شود. پس از گزش پشه و طی دوره کمون، زخمی ایجاد می شود که پس از گذشت مدتی، معمولا بهبود یافته و گاهی از خود جوش باقی می گذارد. درمان بیماری سالک به عوامل متعددی مانند تعداد زخم ها، مدت زمان پیدایش و محل زخم ها و همچنین شرایط سنی و جنسی و اجتماعی بستگی دارد. امروزه برای درمان از روش های شیمیایی، فیزیکی و یا بطور توام استفاده می شود. در این مطالعه داروهای سایمتیدین (Cimetidine) و گلوکانتیم (Glucantime) با مقادیر مختلف برای درمان بیماری لیشمانیوز جلدی (سالک) در موش مورد بررسی قرار گرفته است. موش های خالص نژاد بالب سی (Balb/c) به صورت زیر جلدی با انگل لیشمانیا در قاعده دم عفونی شده و پس از ظهور زخم، به 11 گروه دهه تایی تقسیم شدند و سپس با مقادیر مختلف سایمتیدین و گلوکانتیم بطور مجزا یا مخلوط، تحت درمان قرار گرفتند. از میان رژیم های متعدد درمانی بکار رفته در این تحقیق، استفاده از رژیم ترکیبی شامل سایمتیدین به میزان 80 میلی گرم و گلوکانتیم به مقدار 20 میلی گرم در روز به ازای هر کیلوگرم از وزن بدن از سایر رژیم های درمانی موثرتر بود

Lethal and sublethal effects of endosulfan, imidacloprid and indoxacarb on first instar larvae of Chrysoperla carnea (Neu.: Chrysopidae) under laboratory conditions

The common green lacewing is an important natural enemy used for pest control in greenhouses. It is also very common in many agricultural systems. Hence, studying lethal and sublethal effects of insecticides on this predator would be useful. Toxicity of endosulfan, imidacloprid and indoxacarb was assessed on 1st instar larvae of Chrysoperla carnea (Stephens) in laboratory. Residual bioassays were carried out in glass Petri dishes. The LC50 values, for endosulfan, imidacloprid and indoxacarb were estimated 251, 24.6 and 133 mg ai/l, respectively. Imidacloprid was the most toxic among insecticides tested. To assess the sublethal effects, the 1st instars were treated with LC25 of each insecticide. Thereafter, these effects were studied using fertility life table experiments. The analysis of variance revealed significant difference between treatments and control with respect to developmental time of the 1st instar larvae. However, no significant difference was observed among endosulfan, imidacloprid and indoxacarb treatments considering the larval developmental time. Differences between treatments and control were not significant for the developmental time of the 2nd and 3rd instars, pupae, sex ratio, adult longevity, and adult fertility. The results showed that only net reproduction rate (R0) was significantly affected by treatments. The gross reproductive rate (GRR), intrinsic rate of increase (rm), doubling time (DT), mean generation time (T) and finite rate of increase (λ) were not affected. The highest and the lowest amounts of rm were 0.178 and 0.169 in control and indoxacarb, respectively. Imidacloprid was the most toxic of the insecticides tested on the 1st instar followed by indoxacarb and endosulfan. If results similar to laboratory findings are obtained in field conditions, these insecticides might be appropriate candidates for IPM programs

Effects of imidacloprid, indoxacarb and endosulfan on egg, third-instar larva and pupa of green lacewing Chrysoperla carnea (Neu.: Chrysopidae)

The common green lacewing is a known biocontrol agent because of its wide geographical distribution, high compatibility with different agricultural systems, high searching ability and ease of rearing. Adults and larvae were reared on artificial diet and eggs of Anagasta kuehniella (Zell.) respectively. The toxicity of insecticides was assessed on eggs (dipping method), third-instar larvae (contact method), and pupae (topical application) of Chrysoperla carnea Stephens. In order to study the sublethal effects, the third-instar larvae were treated with recommended field rate of each insecticide. The effects of the insecticides were assessed using demographic toxicology methods. Rearing conditions were 26 ± 2ºC, 60 ± 10% relative humidity and a photoperiod of 16: 8 h (L: D). The results revealed that the insecticides did not affect eggs even at doses higher than recommended field rates. The LD50 values, of endosulfan, imidacloprid and indoxacarb for pupal stage were estimated to be 144, 33, and 21 µg ai/insect respectively. Since the insecticides did not affect the third-instar larvae at the recommended field rate, the LC50 was not estimated for this stage. The results showed that, only net reproduction rate (R0) was significantly affected by treatments. The highest and lowest amounts of rm were 0.176 and 0.152 for control and indoxacarb treatmnets respectively. Based on both acute toxicity and demographic toxicology methods, the rate of toxicity of the tested insecticides was as follows: indoxacarb > endosulfan > imidacloprid

Educational difference in the prevalence of osteoporosis in postmenopausal women: a study in northern Iran

<p>Abstract</p> <p>Background</p> <p>Osteoporosis is the most common metabolic bone disease in the world and it is rapidly increasing in Iran. In this study the relationship between educational levels and osteoporosis was investigated among Iranian postmenopausal women.</p> <p>Method and subjects</p> <p>Seven hundred and six women aged 50-75 years old were randomly recruited from urban (<it>n </it>= 440) and rural (<it>n </it>= 266) areas in Guilan. Osteoporosis was diagnosed by quantitative ultrasound technique and dual X-ray absorptiometry. Serum 25(OH) D3, body weight and height were measured in all subjects. Other data including age, educational level, menopause age, medications and history of illness were also collected.</p> <p>Results</p> <p>We found that the prevalence of osteoporosis was significantly greater among women with low educational level than women with high educational status (18.0% vs 3.8% <it>P </it>< 0.0001). However, women with low educational level had higher mean serum level of vitamin D than women with high educational level. Osteoporosis was significantly more prevalent among women living in rural areas than women living in urban areas (19.1% v.s 13.3%, <it>P </it>< 0.0001).</p> <p>Conclusion</p> <p>This study showed that educational level is associated with bone health in this population of postmenopausal women with significantly higher osteoporosis found in lower social groups. Therefore, we suggest that women with low social level should be carefully evaluated for signs of osteoporosis during routine physical examinations.</p

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

SummaryBackground The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context. Methods We used the comparative risk assessment framework developed for previous iterations of the Global Burden of Disease Study to estimate attributable deaths, disability-adjusted life-years (DALYs), and trends in exposure by age group, sex, year, and geography for 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks from 1990 to 2015. This study included 388 risk-outcome pairs that met World Cancer Research Fund-defined criteria for convincing or probable evidence. We extracted relative risk and exposure estimates from randomised controlled trials, cohorts, pooled cohorts, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. We developed a metric that allows comparisons of exposure across risk factors—the summary exposure value. Using the counterfactual scenario of theoretical minimum risk level, we estimated the portion of deaths and DALYs that could be attributed to a given risk. We decomposed trends in attributable burden into contributions from population growth, population age structure, risk exposure, and risk-deleted cause-specific DALY rates. We characterised risk exposure in relation to a Socio-demographic Index (SDI). Findings Between 1990 and 2015, global exposure to unsafe sanitation, household air pollution, childhood underweight, childhood stunting, and smoking each decreased by more than 25%. Global exposure for several occupational risks, high body-mass index (BMI), and drug use increased by more than 25% over the same period. All risks jointly evaluated in 2015 accounted for 57·8% (95% CI 56·6–58·8) of global deaths and 41·2% (39·8–42·8) of DALYs. In 2015, the ten largest contributors to global DALYs among Level 3 risks were high systolic blood pressure (211·8 million [192·7 million to 231·1 million] global DALYs), smoking (148·6 million [134·2 million to 163·1 million]), high fasting plasma glucose (143·1 million [125·1 million to 163·5 million]), high BMI (120·1 million [83·8 million to 158·4 million]), childhood undernutrition (113·3 million [103·9 million to 123·4 million]), ambient particulate matter (103·1 million [90·8 million to 115·1 million]), high total cholesterol (88·7 million [74·6 million to 105·7 million]), household air pollution (85·6 million [66·7 million to 106·1 million]), alcohol use (85·0 million [77·2 million to 93·0 million]), and diets high in sodium (83·0 million [49·3 million to 127·5 million]). From 1990 to 2015, attributable DALYs declined for micronutrient deficiencies, childhood undernutrition, unsafe sanitation and water, and household air pollution; reductions in risk-deleted DALY rates rather than reductions in exposure drove these declines. Rising exposure contributed to notable increases in attributable DALYs from high BMI, high fasting plasma glucose, occupational carcinogens, and drug use. Environmental risks and childhood undernutrition declined steadily with SDI; low physical activity, high BMI, and high fasting plasma glucose increased with SDI. In 119 countries, metabolic risks, such as high BMI and fasting plasma glucose, contributed the most attributable DALYs in 2015. Regionally, smoking still ranked among the leading five risk factors for attributable DALYs in 109 countries; childhood underweight and unsafe sex remained primary drivers of early death and disability in much of sub-Saharan Africa. Interpretation Declines in some key environmental risks have contributed to declines in critical infectious diseases. Some risks appear to be invariant to SDI. Increasing risks, including high BMI, high fasting plasma glucose, drug use, and some occupational exposures, contribute to rising burden from some conditions, but also provide opportunities for intervention. Some highly preventable risks, such as smoking, remain major causes of attributable DALYs, even as exposure is declining. Public policy makers need to pay attention to the risks that are increasingly major contributors to global burden. Funding Bill & Melinda Gates Foundation

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015:a systematic analysis for the Global Burden of Disease Study 2015

Background Non-fatal outcomes of disease and injury increasingly detract from the ability of the world's population to live in full health, a trend largely attributable to an epidemiological transition in many countries from causes affecting children, to non-communicable diseases (NCDs) more common in adults. For the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015), we estimated the incidence, prevalence, and years lived with disability for diseases and injuries at the global, regional, and national scale over the period of 1990 to 2015.Methods We estimated incidence and prevalence by age, sex, cause, year, and geography with a wide range of updated and standardised analytical procedures. Improvements from GBD 2013 included the addition of new data sources, updates to literature reviews for 85 causes, and the identification and inclusion of additional studies published up to November, 2015, to expand the database used for estimation of non-fatal outcomes to 60 900 unique data sources. Prevalence and incidence by cause and sequelae were determined with DisMod-MR 2.1, an improved version of the DisMod-MR Bayesian meta-regression tool first developed for GBD 2010 and GBD 2013. For some causes, we used alternative modelling strategies where the complexity of the disease was not suited to DisMod-MR 2.1 or where incidence and prevalence needed to be determined from other data. For GBD 2015 we created a summary indicator that combines measures of income per capita, educational attainment, and fertility (the Socio-demographic Index [SDI]) and used it to compare observed patterns of health loss to the expected pattern for countries or locations with similar SDI scores.Findings We generated 9.3 billion estimates from the various combinations of prevalence, incidence, and YLDs for causes, sequelae, and impairments by age, sex, geography, and year. In 2015, two causes had acute incidences in excess of 1 billion: upper respiratory infections (17.2 billion, 95% uncertainty interval [UI] 15.4-19.2 billion) and diarrhoeal diseases (2.39 billion, 2.30-2.50 billion). Eight causes of chronic disease and injury each affected more than 10% of the world's population in 2015: permanent caries, tension-type headache, iron-deficiency anaemia, age-related and other hearing loss, migraine, genital herpes, refraction and accommodation disorders, and ascariasis. The impairment that affected the greatest number of people in 2015 was anaemia, with 2.36 billion (2.35-2.37 billion) individuals affected. The second and third leading impairments by number of individuals affected were hearing loss and vision loss, respectively. Between 2005 and 2015, there was little change in the leading causes of years lived with disability (YLDs) on a global basis. NCDs accounted for 18 of the leading 20 causes of age-standardised YLDs on a global scale. Where rates were decreasing, the rate of decrease for YLDs was slower than that of years of life lost (YLLs) for nearly every cause included in our analysis. For low SDI geographies, Group 1 causes typically accounted for 20-30% of total disability, largely attributable to nutritional deficiencies, malaria, neglected tropical diseases, HIV/AIDS, and tuberculosis. Lower back and neck pain was the leading global cause of disability in 2015 in most countries. The leading cause was sense organ disorders in 22 countries in Asia and Africa and one in central Latin America; diabetes in four countries in Oceania; HIV/AIDS in three southern sub-Saharan African countries; collective violence and legal intervention in two north African and Middle Eastern countries; iron-deficiency anaemia in Somalia and Venezuela; depression in Uganda; onchoceriasis in Liberia; and other neglected tropical diseases in the Democratic Republic of the Congo.Interpretation Ageing of the world's population is increasing the number of people living with sequelae of diseases and injuries. Shifts in the epidemiological profile driven by socioeconomic change also contribute to the continued increase in years lived with disability (YLDs) as well as the rate of increase in YLDs. Despite limitations imposed by gaps in data availability and the variable quality of the data available, the standardised and comprehensive approach of the GBD study provides opportunities to examine broad trends, compare those trends between countries or subnational geographies, benchmark against locations at similar stages of development, and gauge the strength or weakness of the estimates available. Copyright (C) The Author(s). Published by Elsevier Ltd.</p

Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019.

BACKGROUND: The sustainable development goals (SDGs) aim to end HIV/AIDS as a public health threat by 2030. Understanding the current state of the HIV epidemic and its change over time is essential to this effort. This study assesses the current sex-specific HIV burden in 204 countries and territories and measures progress in the control of the epidemic. METHODS: To estimate age-specific and sex-specific trends in 48 of 204 countries, we extended the Estimation and Projection Package Age-Sex Model to also implement the spectrum paediatric model. We used this model in cases where age and sex specific HIV-seroprevalence surveys and antenatal care-clinic sentinel surveillance data were available. For the remaining 156 of 204 locations, we developed a cohort-incidence bias adjustment to derive incidence as a function of cause-of-death data from vital registration systems. The incidence was input to a custom Spectrum model. To assess progress, we measured the percentage change in incident cases and deaths between 2010 and 2019 (threshold >75% decline), the ratio of incident cases to number of people living with HIV (incidence-to-prevalence ratio threshold <0·03), and the ratio of incident cases to deaths (incidence-to-mortality ratio threshold <1·0). FINDINGS: In 2019, there were 36·8 million (95% uncertainty interval [UI] 35·1-38·9) people living with HIV worldwide. There were 0·84 males (95% UI 0·78-0·91) per female living with HIV in 2019, 0·99 male infections (0·91-1·10) for every female infection, and 1·02 male deaths (0·95-1·10) per female death. Global progress in incident cases and deaths between 2010 and 2019 was driven by sub-Saharan Africa (with a 28·52% decrease in incident cases, 95% UI 19·58-35·43, and a 39·66% decrease in deaths, 36·49-42·36). Elsewhere, the incidence remained stable or increased, whereas deaths generally decreased. In 2019, the global incidence-to-prevalence ratio was 0·05 (95% UI 0·05-0·06) and the global incidence-to-mortality ratio was 1·94 (1·76-2·12). No regions met suggested thresholds for progress. INTERPRETATION: Sub-Saharan Africa had both the highest HIV burden and the greatest progress between 1990 and 2019. The number of incident cases and deaths in males and females approached parity in 2019, although there remained more females with HIV than males with HIV. Globally, the HIV epidemic is far from the UNAIDS benchmarks on progress metrics. FUNDING: The Bill & Melinda Gates Foundation, the National Institute of Mental Health of the US National Institutes of Health (NIH), and the National Institute on Aging of the NIH